Scandinavian Critical Care Trials Group Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2003
NCT00922714
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Scandinavian Critical Care Trials Group